Cancer Letters
Multi-functional extracellular vesicles: Potentials in cancer immunotherapy
Publication date: Available online 30 September 2022Source: Cancer LettersAuthor(s): Ling Zhang, Mengchi Sun, Zhonggui He, Jin Sun, Heran Li, Qiuhua Luo
Cancer Letters
TGF-β signaling networks in the tumor microenvironment
Publication date: Available online 29 September 2022Source: Cancer LettersAuthor(s): Max Kam-Kwan Chan, Jeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Alex Siu-Wing Chan, Johnny Yuk-Yeung Ho, Tony Pak-Tik Lin, Jiaoyi Chen, Kam-Tong Leung, Ka-Fai To, Hui-Ya…
Cancer Letters
<em>DANCR</em> deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model
Publication date: Available online 29 September 2022Source: Cancer LettersAuthor(s): Xiaojie Gan, Dongyang Ding, Mengchao Wang, Yuan Yang, Dapeng Sun, Wen Li, Wenbin Ding, Fu Yang, Weiping Zhou, Shengxian Yuan
Cancer Letters
Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model
Publication date: Available online 29 September 2022Source: Cancer LettersAuthor(s): Laura Hartmann, Wolfram Osen, Oliver L. Eichmüller, Theresa Kordaß, Jennifer Furkel, Elke Dickes, Carissa Reid, Jürgen Debus, Stephan Brons, Amir Abdollahi, Mahmoud Mo…
Cancer Letters
Corrigendum to “SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission” [Canc. Lett. 547 (2022) 215871]
Publication date: 28 November 2022Source: Cancer Letters, Volume 549Author(s): Miao Wang, Ranru Wei, Guohui Li, Hai-Lian Bi, Zhaojun Jia, Mengjie Zhang, Mengyao Pang, Xiaona Li, Liming Ma, Ying Tang
Cancer Letters
Prostate cancer treatment – China’s perspective
Publication date: Available online 24 September 2022Source: Cancer LettersAuthor(s): Jiazhou Liu, Liang Dong, Yinjie Zhu, Baijun Dong, Jianjun Sha, Helen He Zhu, Jiahua Pan, Wei Xue
Cancer Letters
N4BP3 promotes breast cancer metastasis via NEDD4-mediated E-cadherin ubiquitination and degradation
Publication date: Available online 23 September 2022Source: Cancer LettersAuthor(s): Meng Luo, Jinfan Li, Qi Yang, Song Xu, Kun Zhang, Jing Chen, Suzhan Zhang, Shu Zheng, Jiaojiao Zhou
Cancer Letters
Corrigendum to “ 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling” [Canc. Lett. 471 (2020) 135–146]
Publication date: 28 November 2022Source: Cancer Letters, Volume 549Author(s): Yangyang Yue, Weikun Qian, Jie Li, Shiqi Wu, Mengzhao Zhang, Zheng Wu, Qingyong Ma, Zheng Wang
Cancer Letters
Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming
Publication date: Available online 20 September 2022Source: Cancer LettersAuthor(s): Cai Zhang, Lijie Zhou, Songyang Li, Junwei Zhao, Xianchun Meng, Liwei Ma, Yongfeng Wang, Cai Li, Lu Zheng, Liang Ming
Cancer Letters
Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer
Publication date: Available online 17 September 2022Source: Cancer LettersAuthor(s): Shuchang Wang, Lulu Wo, Zizhen Zhang, Chunchao Zhu, Chaojie Wang, Yangyang Wang, Lechun Hou, Hui Cao, Qian Zhao, Enhao Zhao